Paride Grisenti

No ORCID on file · 1 paper in corpus
other 2023
Molecules (Basel, Switzerland) ·doi:10.3390/molecules28093861

Elagolix sodium salt is the first marketed orally active non-peptide gonadotropin-releasing hormone receptor antagonist (GnRHR-ant) for the management of hormone dependent diseases, such as endometriosis and uterine fibroids. Despite its pr…